Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
Lack of cell cycle regulation of telomerase activity in human cellsS E Holt, D L Aisner, J W Shay, et al.
Molecular Cell Biology Research Communications : MCBRC|August 31, 2000
Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeresP A McChesney, D L Aisner, B C Frank, et al.
Biochemical and Biophysical Research Communications|January 28, 1999
Telomerase activity does not always imply telomere maintenanceM M Ouellette, D L Aisner, I Savre-Train, et al.
Neoplasia (New York, N.Y.)|February 24, 2001
An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activityX Yi, D M White, D L Aisner, et al.
Molecular and Cellular Biology|August 24, 1999
Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitroV M Tesmer, L P Ford, S E Holt, et al.
Diagnostic Cytopathology|November 22, 2011
Evaluation of EGFR mutation status in cytology specimens: an institutional experienceD L Aisner, C Deshpande, Z Baloch, et al.
NPJ Precision Oncology|October 13, 2021
Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLCT L Peters, T Patil, A T Le, et al.
Genes & Development|April 10, 1999
Functional requirement of p23 and Hsp90 in telomerase complexesS E Holt, D L Aisner, J Baur, et al.
Nature Medicine|October 29, 2013
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancerA Vaishnavi, M Capelletti, A T Le, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2015
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancerB H O'Neil, A J Scott, W W Ma, et al.
Pageof 1